推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Translational Oncology 期刊收藏夹

2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
聚合物期刊JPM征稿|IF持续上升 + APC折扣
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Translational Oncology期刊基本信息Hello,您是该期刊的第114706位访客

基本信息 登录收藏
期刊名字Translational OncologyTranslational Oncology

TRANSL ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.8
70人评分
我要评分

声誉
6.6

影响力
5.1

速度
6.2

期刊ISSN1936-5233
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
2024-2025最新影响因子
(数据来源于搜索引擎)
4.1 点击查看影响因子趋势图
实时影响因子 截止2026年5月06日:4.9
2024-2025自引率2.4%点击查看自引率趋势图
五年影响因子4.6
JCI期刊引文指标 1.05
h-index 41
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
7.301.3830.911
学科分区排名百分位
大类:Medicine
小类:Oncology
Q180 / 428
大类:Medicine
小类:Cancer Research
Q271 / 233

期刊简介
Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.
期刊官方网站https://www.journals.elsevier.com/translational-oncology
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/TRANON
该期刊中国学者近期发文 - NewPARP inhibitors target cellular energy metabolism: Mechanisms of action and clinical implications
Author: Li, Jiajia; Mu, Degong; Li, Jin; Lan, Maozhuo; Wu, Wei; Zhang, Songling; Dai, Yun
Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 68, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102757


Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patients
Author: Zhu, Li; Liu, Yang; Lan, Jianjun; Cai, Erdong; Sun, Dongmei; Liu, Jibin; Zong, Li; Cong, Zhirong
Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 68, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102770


Transcriptomic and single-cell analyses reveal the prognostic value of ETV4 and its role in shaping the immune landscape of colorectal cancer
Author: Meng, Ruipeng; Wang, Shilong; She, Zhanfei; Wang, Huaiming; Wu, Bo; Qiao, Yu; Chen, Pengyuan; Nargerel; Yang, Xiaofeng; Wang, Liang
Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 68, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102775


Statins targeting mevalonate-geranylgeranyl diphosphate pathway inhibit proliferation in NK/T lymphoma by promoting pyroptosis
Author: Wang, Yingjun; Mei, Mei; Wang, Jieting; Wei, Lai; Zhang, Mengqian; Zhang, Mingzhi
Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102747


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Translational Oncology的语言要求,还能让Translational Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Translational Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2930; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:translational oncology、cancer、genetics、endocrinology、tumour
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardPeer review
通讯方式NEOPLASIA PRESS, 1150 W MEDICAL CENTER DR, MSRB III, RM 9303, ANN ARBOR, USA, MI, 48109-0648
出版商Neoplasia Press
涉及的研究方向Biochemistry, Genetics and Molecular Biology-Cancer Research
出版国家或地区UNITED STATES
出版语言English
出版周期Quarterly
出版年份2007
年文章数 381点击查看年文章数趋势图
Gold OA文章占比99.25%
研究类文章占比:
文章 ÷(文章 + 综述)
97.11%
WOS期刊JCR分区
2024-2025年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ291/328
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ175/328
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 3区3区3区
ONCOLOGY
肿瘤学
4区3区3区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 4区3区3区
ONCOLOGY
肿瘤学
4区4区3区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区2区
ONCOLOGY
肿瘤学
3区4区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1936-5233%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
平均录用比例网友分享经验:
较易
版面费/APC文章处理费信息
文章处理费:需要( USD2930; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Translational Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 Translational Oncology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Translational Oncology期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Translational Oncology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Cancer Communications040.30
    CELLULAR ONCOLOGY08.60
    Journal of Gastric Cancer227.80
    Frontiers in Oncology606.60
    Advances in Cancer Biology Metastasis08.10
    International Journal of Medical Biochemistry00.90
    Critical Reviews in Oncogenesis02.70
    Clinical and Experimental Morphology00.70
    Molecular and Cellular Oncology03.00
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE883331
    JOURNAL OF ETHNOPHARMACOLOGY790287
    Frontiers in Immunology726517
    BIOMEDICINE & PHARMACOTHERAPY713603
    BIOMATERIALS705388
    Frontiers in Pharmacology699659
    PHYTOMEDICINE625941
    Frontiers in Oncology608456
    IEEE Journal of Biomedical and Health Informatics582387
    Biomedical Signal Processing and Control582059
  •  

    Translational Oncology Translational Oncology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.PARP inhibitors target cellular energy metabolism: Mechanisms of action and clinical implications

    Author: Li, Jiajia; Mu, Degong; Li, Jin; Lan, Maozhuo; Wu, Wei; Zhang, Songling; Dai, Yun
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 68, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102757
        PubMed      DOI
    2.Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patients

    Author: Zhu, Li; Liu, Yang; Lan, Jianjun; Cai, Erdong; Sun, Dongmei; Liu, Jibin; Zong, Li; Cong, Zhirong
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 68, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102770
        PubMed      DOI
    3.Transcriptomic and single-cell analyses reveal the prognostic value of ETV4 and its role in shaping the immune landscape of colorectal cancer

    Author: Meng, Ruipeng; Wang, Shilong; She, Zhanfei; Wang, Huaiming; Wu, Bo; Qiao, Yu; Chen, Pengyuan; Nargerel; Yang, Xiaofeng; Wang, Liang
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 68, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102775
        PubMed      DOI
    4.Statins targeting mevalonate-geranylgeranyl diphosphate pathway inhibit proliferation in NK/T lymphoma by promoting pyroptosis

    Author: Wang, Yingjun; Mei, Mei; Wang, Jieting; Wei, Lai; Zhang, Mengqian; Zhang, Mingzhi
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102747
        PubMed      DOI
    5.EGR1 lactylation induces tumor cell senescence and immunosuppressive microenvironment in intrahepatic cholangiocarcinoma

    Author: Liang, Yuan; Zhang, Rui; Li, Yu; Wang, Hao; Qiao, Lei; Bu, Qingfa; Xu, Zibo; Liu, Zheng; Song, Ziyan; Huang, Tianning; Liu, Mu; Zhou, Jinren; Wang, Qi; Chen, Qiuyang; Lu, Ling
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102750
        PubMed      DOI
    6.Pan-cancer analysis identifies FKBP10 as a regulator of tumor immunosuppression and therapeutic response

    Author: Li, Yan; Chen, Jian; Li, Siyan; Tu, Gang; Tang, Lingfeng
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102749
        PubMed      DOI
    7.Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway

    Author: Abd El-Salam, Mohamed; Chen, Wu; Tang, Yan; Rao, Ting; Kang, Xuejia; Sun, Lifang; Han, Tiegang; Chen, Pengyu; Mossanen, Matthew; Cheng, Fan; Yang, Chun; Pan, Chong-Xian
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102753
        PubMed      DOI
    8.Single-cell transcriptome analysis indicated that immune-related programmed cell death modification features could predict the clinical outcomes of patients with ovarian cancer

    Author: Sun, Jieyun; Jing, Li; Zhu, Xiangfei; Yang, Huan; Sun, Yu; Lu, Xiaoyuan; Liu, Zhao
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102752
        PubMed      DOI
    9.Single-cell transcriptomic analysis reveals that the circRNA circGCLM promotes tumorigenesis and confers cisplatin resistance in NSCLC through the miR-505-3p/ERBB4 axis

    Author: Ma, Yirou; Huang, Baiqing; Wang, Haiyang; Xue, Mengchao; Liu, Yiyang; Jin, Yibo; Wang, Chunping; Gu, Shaorui; Zhou, Yongxin
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102759
        PubMed      DOI
    10.NF-κB signaling in hepatocellular carcinoma: Mechanisms of tumor progression, immune evasion, and therapeutic resistance

    Author: Yang, Ping; Li, Xiaoli; Yang, Lin; Xiao, Na; Ren, Lili; Ji, Mengmeng; Yang, Hua
    Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 67, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102760
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS DRUG DISCOVERY289159.20
    Kidney International Supplements24117.70
    LANCET70092.40
    Nature Reviews Clinical Oncology127126.60
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    NATURE REVIEWS CANCER39696.20
    World Psychiatry6184.80
    World Psychiatry7084.80
    ANNALS OF ONCOLOGY21069.60
    同分区等级的其他期刊名称 h-index CiteScore
    AI Open031.30
    Qualitative Psychology03.90
    Foundations and Trends in Information Retrieval2524.20
    COMMUNICATIONS OF THE ACM18914.10
    Business & Information Systems Engineering018.50
    Business & Information Systems Engineering018.50
    Advanced Sensor and Energy Materials03.70
    Battery Energy015.10
    Foundations and Trends in Computer Graphics and Vision032.80
    Ukrainian Journal of Physical Optics149.60
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共22


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室